BBOTVSEOCN• 12 Months (Normalized)
BBOT vs EOCN (BridgeBio Oncology Therapeutics Inc. vs Eocene Ltd.)
Showing Closing Date Range from Oct 7, 2025 to Oct 7, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BBOT Performance $3.44
-71.83%
BridgeBio Oncology Therapeutics Inc.
Normalized Baseline0.00%
EOCN Performance $3.46
-0.92%
Eocene Ltd.
Normalized Baseline0.00%
Alpha Spread Margin EOCN LEADS
-70.91 pts
EOCN outperforming by 70.91 percentage points
BBOTEOCN
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BBOT EOCN
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(252 dates)
| Date | BBOT Price | BBOT Gain (%) | EOCN Price | EOCN Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 07, 2026 | $3.44 | -71.83% | $3.46 | -0.92% | -70.91% |
| Oct 06, 2026 | $3.50 | -71.33% | $3.36 | -3.72% | -67.61% |
| Oct 05, 2026 | $3.60 | -70.52% | $3.45 | -1.15% | -69.37% |
| Oct 02, 2026 | $3.89 | -68.14% | $3.61 | +3.44% | -71.58% |
| Oct 01, 2026 | $- | $3.41 | -2.44% | - | |
| Sep 30, 2026 | $4.10 | -66.42% | $3.49 | +0.00% | -66.42% |
| Sep 29, 2026 | $3.92 | -67.90% | $- | - | |
| Sep 28, 2026 | $3.81 | -68.80% | $- | - | |
| Sep 25, 2026 | $3.95 | -67.65% | $- | - | |
| Sep 24, 2026 | $3.99 | -67.32% | $- | - | |
| Sep 23, 2026 | $4.16 | -65.93% | $- | - | |
| Sep 22, 2026 | $4.66 | -61.83% | $- | - | |
| Sep 21, 2026 | $4.66 | -61.83% | $- | - | |
| Sep 18, 2026 | $4.77 | -60.93% | $- | - | |
| Sep 17, 2026 | $4.89 | -59.95% | $- | - |
Page 1 of 17